Teodora Kurteva, MD
NPI 1891079232 · Urology Physician · North Andover, MA
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1891079232
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 264958 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
14 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
8,084 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Chemical Analysis Using Spectrophotometry (light)84311 | 1,250 | $8 |
| Ketone Bodies Analysis, Quantitative82010 | 628 | $8 |
| Bilirubin Level, Total82247 | 628 | $5 |
| Glucose (sugar) Level on Body Fluid82945 | 628 | $4 |
| Urine Hemoglobin Level83069 | 628 | $4 |
| Body Fluid Ph Level83986 | 628 | $4 |
| Total Protein Level, Urine84156 | 628 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 30 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 507 | 151 |
| Finasteride | 301 | 71 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 275 | 179 |
| Vibegronbrand: Gemtesa | 265 | 81 |
| Mirabegronbrand: Myrbetriq | 219 | 93 |
| Estradiol | 118 | 72 |
| Cephalexin | 101 | 76 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$407 across 18 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-10-04
- Last updated
- 2015-09-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.